Esperion Therapeutics Inc (ESPR)
Operating Cash Flow (Statement)
-$18.19M
TTM · Period ending: · USD
ESPR Operating Cash Flow (Statement)
Latest reported-$18.19Mperiod ending
Latest reported-$18.19Mperiod ending
ESPR Cash from Operations (-$7.85M → -$18.19M)
Annual operating cash flow (statement)
High-resolution chart · PNG
ESPR operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -13,093,000 | |
| -23,654,000 | |
| -135,487,000 | |
| -174,827,000 | |
| -263,809,000 | |
| -85,177,000 | |
| -70,341,000 | |
| -148,638,000 | |
| -131,302,000 | |
| -47,730,000 | |
| -38,156,000 | |
| -32,021,000 | |
| -18,113,361 | |
| -10,808,567 | |
| -9,068,725 | |
| -26,564,000 | |
| -22,767,000 | |
| -17,954,000 | |
| -7,852,572 |